Innovation

Biomarker for HIV-1 Infection

Temple University
posted on 08/05/2011

This invention relates to measurements of monocyte CD 163, a monocyte/macrophage-specific scavenger receptor for hemoglobin-haptoglobin complex, mean fluorescence intensity and frequency measurements in blood which is an important surrogate marker for clinical management of HIV-1 infected individuals. This marker may be used to predict disease progression, viral load and changes in viral load, and may be important in diagnosis and or risk assessment relative to CNS and other neurological manifestations of HIV infection.

Suggested Uses

• Useful for monitoring the course of HIV-1 infection and/or HIV Encephalopathy.


Innovation Details
 

File Number: 546JR 


IP Protection

Patent Number(s): 12/301796

License Online

This innovation currently is not available for online licensing. Please contact Stephen Nappi at Temple University for more information.

Request more info via email request more info
People

Case Manager:

Stephen Nappi Stephen Nappi

Innovations (0)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

8,805 members 16,684 innovations 159 organizations

Browse

Alan Thomas, Director, UChicagoTech

"The iBridge Network has opened up new avenues for innovations at UChicagoTech. Relationships between researchers from other universities or industry can be built and strengthened, while investors can find new technologies to advance. "  read more...